Botanix Pharmaceuticals Limited (BXPHF)

Botanix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	161	411	417	114	38	58
Market Cap Growth	-67.54%	-1.25%	266.90%	197.13%	-34.52%	122.85%
Enterprise Value	115	380	404	108	27	44
Last Close Price	0.09	0.29	0.24	0.06	0.04	0.07
PS Ratio	42.34	108.40	301.75	45.23	20.14	11.30
PB Ratio	3.02	7.72	5.74	7.43	6.81	3.74
P/TBV Ratio	4.61	11.80	7.88	10.60	11.42	3.74
EV/Sales Ratio	28.12	100.19	292.90	42.93	14.09	8.56
Debt / Equity Ratio	0.02	0.02	-	-	0.02	0.01
Asset Turnover	0.05	0.05	0.03	0.19	0.15	0.29
Inventory Turnover	0.26	0.26	1.68	1.85	-	-
Quick Ratio	2.74	2.74	21.47	5.70	1.26	20.81
Current Ratio	4.00	4.00	22.21	7.42	1.78	20.82
Return on Equity (ROE)	-90.93%	-90.93%	-21.07%	-58.86%	-90.98%	-15.00%
Return on Assets (ROA)	-42.91%	-42.91%	-12.74%	-29.35%	-45.80%	-8.94%
Return on Capital Employed (ROCE)	-79.60%	-79.60%	-12.90%	-39.80%	-161.80%	-16.20%
Earnings Yield	-35.25%	-13.77%	-2.22%	-5.37%	-23.74%	-4.28%
FCF Yield	-32.18%	-12.57%	-1.32%	-7.08%	-20.18%	-3.82%
Buyback Yield / Dilution	-22.87%	-22.87%	-30.12%	-18.58%	-0.02%	-3.91%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.